Ozempic vs Mounjaro: Which GLP-1 Drug Is Right for You?
Verdict Summary
Mounjaro (tirzepatide) produces greater average weight loss in clinical trials due to its dual GIP/GLP-1 mechanism. Ozempic (semaglutide) has a longer safety track record and broader insurance coverage.
Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →
At a Glance
| Dimension | Ozempic | Mounjaro |
|---|---|---|
| Drug Class | GLP-1 agonist | GIP + GLP-1 dual agonist |
| Avg. Weight Loss | ~15% body weight | ~20-22% body weight |
| FDA Approved | Diabetes + Obesity | Diabetes + Obesity |
| Dosing | Once weekly | Once weekly |
| Cost | ~$900-$1,000/month | ~$1,000-$1,100/month |
Ozempic Deep Dive
Ozempic (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin secretion. It has been on the market since 2017 with an extensive safety database across millions of patients.
How to Choose
Choose Ozempic if…
- •You want the more established safety record
- •Insurance coverage is a priority
- •You have responded well to GLP-1 monotherapy previously
Choose Mounjaro if…
- •Maximum weight loss is your primary goal
- •You have not responded adequately to GLP-1 monotherapy
- •You want the most clinically studied dual agonist
Consider Both If…
Both are appropriate first-line options for obesity treatment; the choice is often driven by insurance coverage and prescriber preference.
Frequently Asked Questions
More Comparisons
BPC-157 vs TB-500
BPC-157 excels at localized tendon, ligament, and gut healing. TB-500 is better for systemic muscle recovery and widespread inflammation.
Semaglutide vs Tirzepatide
Tirzepatide produces greater average weight loss in clinical trials. Semaglutide has a longer post-market safety record. Both are excellent options.
Ipamorelin vs CJC-1295
Ipamorelin and CJC-1295 work through complementary mechanisms and are almost always used together rather than as alternatives.
Ozempic vs Wegovy
Ozempic and Wegovy both contain Semaglutide. The difference is FDA indication and maximum dose — Wegovy is approved for weight management at higher doses.
Mounjaro vs Zepbound
Mounjaro and Zepbound both contain Tirzepatide. Mounjaro is approved for Type 2 diabetes; Zepbound for obesity. The active ingredient is identical.
Selank vs Semax
Selank is primarily anxiolytic — it reduces anxiety and improves mood. Semax is primarily a cognitive enhancer — it boosts focus, memory, and BDNF. They are frequently combined.